Quintiles Transitional Holdings Inc. (Q) Stock Rating Reaffirmed by Citigroup Inc.

Quintiles Transitional Holdings Inc. (NYSE:Q)‘s stock had its “neutral” rating reiterated by equities researchers at Citigroup Inc. in a note issued to investors on Wednesday. They presently have a $96.00 target price on the medical research company’s stock, up from their prior target price of $87.00. Citigroup Inc.’s price objective would indicate a potential upside of 7.30% from the company’s previous close.

Several other analysts also recently commented on the stock. Credit Suisse Group reissued an “outperform” rating and issued a $96.00 target price (up from $94.00) on shares of Quintiles Transitional Holdings in a research report on Tuesday, June 6th. Jefferies Group LLC boosted their target price on shares of Quintiles Transitional Holdings from $78.00 to $81.00 and gave the stock a “hold” rating in a research report on Monday, May 15th. Evercore ISI reissued an “in-line” rating and issued a $88.50 target price (up from $84.00) on shares of Quintiles Transitional Holdings in a research report on Thursday, May 4th. Mizuho boosted their target price on shares of Quintiles Transitional Holdings from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Thursday, May 4th. Finally, Zacks Investment Research downgraded shares of Quintiles Transitional Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, April 26th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $85.59.

Quintiles Transitional Holdings (NYSE Q) traded up 0.26% during midday trading on Wednesday, reaching $89.70. 90,733 shares of the company traded hands. Quintiles Transitional Holdings has a 12 month low of $61.21 and a 12 month high of $90.32. The stock has a market capitalization of $19.74 billion, a price-to-earnings ratio of 198.45 and a beta of 0.64. The firm has a 50 day moving average of $85.16 and a 200-day moving average of $80.17.

Quintiles Transitional Holdings (NYSE:Q) last posted its earnings results on Wednesday, May 3rd. The medical research company reported $1.01 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.06. The company had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.91 billion. Quintiles Transitional Holdings had a net margin of 1.06% and a return on equity of 18.03%. The company’s revenue for the quarter was up 72.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.89 earnings per share. Analysts forecast that Quintiles Transitional Holdings will post $4.54 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was first published by sleekmoney and is the property of of sleekmoney. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://sleekmoney.com/quintiles-transitional-holdings-inc-q-stock-rating-reaffirmed-by-citigroup-inc/1946301.html.

In related news, Director Jack M. Greenberg sold 6,092 shares of the company’s stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $82.50, for a total transaction of $502,590.00. Following the completion of the transaction, the director now directly owns 2,930 shares in the company, valued at approximately $241,725. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John G. Danhakl sold 761,143 shares of the company’s stock in a transaction on Tuesday, May 30th. The shares were sold at an average price of $84.01, for a total transaction of $63,943,623.43. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,758,400 shares of company stock valued at $735,783,985. Corporate insiders own 6.40% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Parsons Capital Management Inc. RI bought a new position in Quintiles Transitional Holdings during the first quarter valued at approximately $1,430,000. Piedmont Investment Advisors LLC boosted its position in Quintiles Transitional Holdings by 434.1% in the first quarter. Piedmont Investment Advisors LLC now owns 18,222 shares of the medical research company’s stock valued at $1,467,000 after buying an additional 14,810 shares during the last quarter. Teachers Retirement System of The State of Kentucky boosted its position in Quintiles Transitional Holdings by 103.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 132,300 shares of the medical research company’s stock valued at $10,654,000 after buying an additional 67,300 shares during the last quarter. Achmea Investment Management B.V. bought a new position in Quintiles Transitional Holdings during the first quarter valued at approximately $1,802,000. Finally, Point72 Asset Management L.P. bought a new position in Quintiles Transitional Holdings during the first quarter valued at approximately $18,168,000. Hedge funds and other institutional investors own 92.54% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/quintiles-transitional-holdings-inc-q-stock-rating-reaffirmed-by-citigroup-inc/1946301.html

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *